Matches in Wikidata for { <http://www.wikidata.org/entity/Q102154580> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q102154580 description "clinical trial" @default.
- Q102154580 description "ensayo clínico" @default.
- Q102154580 description "ensayu clínicu" @default.
- Q102154580 description "klinisch onderzoek" @default.
- Q102154580 description "клінічне випробування" @default.
- Q102154580 description "临床试验" @default.
- Q102154580 name "Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment" @default.
- Q102154580 name "Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment" @default.
- Q102154580 type Item @default.
- Q102154580 label "Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment" @default.
- Q102154580 label "Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment" @default.
- Q102154580 prefLabel "Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment" @default.
- Q102154580 prefLabel "Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment" @default.
- Q102154580 P1050 Q102154580-FFEA8314-7D17-468C-81F2-C2FC9306D3E9 @default.
- Q102154580 P1132 Q102154580-79207FC3-FE0C-49AE-801B-F5E06C7D3D76 @default.
- Q102154580 P1476 Q102154580-3AF98B6E-04DB-4F49-A195-FE1774BD301C @default.
- Q102154580 P1813 Q102154580-1B5028E0-F2AD-4554-AF11-2DAC89E50DFA @default.
- Q102154580 P2899 Q102154580-E58333ED-51AD-4A35-BDAF-E44B454B272F @default.
- Q102154580 P3098 Q102154580-D4D0D8EE-F0FF-4908-8269-017451C2DA62 @default.
- Q102154580 P31 Q102154580-7E8358E8-3874-4782-BDFD-D31648C4EFF8 @default.
- Q102154580 P4844 Q102154580-D221639B-D4D6-4478-A56F-46C8BB442973 @default.
- Q102154580 P580 Q102154580-8023D099-4287-4907-807B-513DCEFB5A90 @default.
- Q102154580 P582 Q102154580-42D9F064-5B5B-418D-80C4-828D45471CA7 @default.
- Q102154580 P6099 Q102154580-12AF6CBA-6B6A-4AEA-A38C-00A76C641A0E @default.
- Q102154580 P8005 Q102154580-558AE99E-7F4A-4A22-BCCC-8640A6EFE4F6 @default.
- Q102154580 P8363 Q102154580-11B5E994-A708-4090-BF4F-31D8FB97B59B @default.
- Q102154580 P859 Q102154580-DC563E37-9BE4-4428-9DFB-88C47ADB4F47 @default.
- Q102154580 P921 Q102154580-4EAFE98D-05D9-42E2-BC5B-5250630883D0 @default.
- Q102154580 P1050 Q170990 @default.
- Q102154580 P1132 "+310" @default.
- Q102154580 P1476 "A 28-week, Randomized, Double-blind, Active Controlled, Multicenter Study to Evaluate the Efficacy of Subcutaneously Administered Secukinumab Compared to Ustekinumab in Adult Patients With Psoriatic Arthritis and Failure of TNFα- Inhibitor Treatment (AgAIN)" @default.
- Q102154580 P1813 "AgAIN" @default.
- Q102154580 P2899 "+18" @default.
- Q102154580 P3098 "NCT04632927" @default.
- Q102154580 P31 Q30612 @default.
- Q102154580 P4844 Q420305 @default.
- Q102154580 P580 "2020-11-26T00:00:00Z" @default.
- Q102154580 P582 "2022-06-15T00:00:00Z" @default.
- Q102154580 P6099 Q42824827 @default.
- Q102154580 P8005 Q76649614 @default.
- Q102154580 P8363 Q78089383 @default.
- Q102154580 P859 Q507154 @default.
- Q102154580 P921 Q511097 @default.